Showing results (781-790 of 1,826) with videos related to
Sort By:
Pageof 183
Signal Transduction and Targeted Therapy|September 24, 2024
Pre-metastatic niche: formation, characteristics and therapeutic implicationYuhang Wang, Jiachi Jia, Fuqi Wang, et al.Signal Transduction and Targeted Therapy|September 10, 2024
Emerging and reemerging infectious diseases: global trends and new strategies for their prevention and controlShen Wang, Wujian Li, Zhenshan Wang, et al.Signal Transduction and Targeted Therapy|March 7, 2024
Ferroptosis in cancer: From molecular mechanisms to therapeutic strategiesQian Zhou, Yu Meng, Daishi Li, et al.Signal Transduction and Targeted Therapy|March 6, 2024
Anti-metabolic agent pegaspargase plus PD-1 antibody sintilimab for first-line treatment in advanced natural killer T cell lymphomaJie Xiong, Shu Cheng, Xiao Gao, et al.Signal Transduction and Targeted Therapy|February 29, 2024
Contactin-associated protein-like 2 (CNTNAP2) mutations impair the essential α-secretase cleavages, leading to autism-like phenotypesQing Zhang, Mengen Xing, Zhengkai Bao, et al.Signal Transduction and Targeted Therapy|March 7, 2024
Targeting carnitine palmitoyl transferase 1A (CPT1A) induces ferroptosis and synergizes with immunotherapy in lung cancerLei Ma, Chong Chen, Chunxing Zhao, et al.Signal Transduction and Targeted Therapy|February 26, 2024
Precise genome-editing in human diseases: mechanisms, strategies and applicationsYanjiang Zheng, Yifei Li, Kaiyu Zhou, et al.Signal Transduction and Targeted Therapy|November 23, 2023
Multifunctional mesoporous silica nanoparticles for biomedical applicationsBolong Xu, Shanshan Li, Rui Shi, et al.Signal Transduction and Targeted Therapy|November 7, 2023
The tumor-enriched small molecule gambogic amide suppresses glioma by targeting WDR1-dependent cytoskeleton remodelingJiaorong Qu, Bojun Qiu, Yuxin Zhang, et al.Signal Transduction and Targeted Therapy|October 26, 2023
Camrelizumab (a PD-1 inhibitor) plus apatinib (an VEGFR-2 inhibitor) and hepatic artery infusion chemotherapy for hepatocellular carcinoma in Barcelona Clinic Liver Cancer stage C (TRIPLET): a phase II studyTian-Qi Zhang, Zhi-Jun Geng, Meng-Xuan Zuo, et al.Pageof 183